We are live on ! Find out more
NEPH icon

Nephros
NEPH

21 hedge funds and large institutions have $28.9M invested in Nephros in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

534% more capital invested

Capital invested by funds: $4.56M → $28.9M (+$24.4M)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

62% more funds holding

Funds holding: 13 → 21 (+8)

42.84% more ownership

Funds ownership: 5.76% → 48.6% (+43%)

Holders
21
Holders Change
+8
Holders Change %
+61.54%
% of All Funds
0.46%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WC
Wexford Capital
Florida
+$28.8M
2
BA
Bard Associates
Illinois
+$1.76M
3
CPA
Cowen Prime Advisors
New York
+$1.31M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$482K
5
PHP
Parkman Healthcare Partners
Connecticut
+$438K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$21.1K
2
ISL
Ingalls & Snyder LLC
New York
-$11.9K
3
Deutsche Bank
Deutsche Bank
Germany
-$1K
4
UBS Group
UBS Group
Switzerland
-$934

NEPH Hedge Fund Activity: Q1 2020 in Review

21 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2020, worth a combined $28.9M — up 534% from $4.56M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NEPH positions and 1 closed out — a net gain of 9 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Wexford Capital, opening a new position worth an estimated $28.8M. The largest seller was Millennium Management, cutting an estimated $21.1K.

  • 21 institutional investors held Nephros (NEPH) as of Q1 2020, up from 13 in Q4 2019.
  • Funds reported $28.9M of Nephros stock for Q1 2020, up 534% quarter-over-quarter.
  • 10 funds opened new Nephros positions in Q1 2020 and 1 closed out, a net change of +9 holders.
  • The largest Nephros buyer in Q1 2020 was Wexford Capital, an estimated $28.8M added.
  • The largest Nephros seller in Q1 2020 was Millennium Management, an estimated $21.1K sold.

Based on aggregated 13F filings for Q1 2020.